Annovis Total Assets vs Net Invested Capital Analysis

ANVS Stock

USD 6.65 0.14 2.06%

Annovis Bio financial indicator trend analysis is way more than just evaluating Annovis Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Annovis Bio is a good investment. Please check the relationship between Annovis Bio Total Assets and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Total Assets vs Net Invested Capital

Total Assets vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Annovis Bio Total Assets account and Net Invested Capital. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Annovis Bio's Total Assets and Net Invested Capital is 0.89. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Annovis Bio, assuming nothing else is changed. The correlation between historical values of Annovis Bio's Total Assets and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Annovis Bio are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Total Assets i.e., Annovis Bio's Total Assets and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Total Assets

Total assets refers to the total amount of Annovis Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Annovis Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most indicators from Annovis Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Annovis Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.At this time, Annovis Bio's Selling General Administrative is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 16.2 M in 2024, whereas Discontinued Operations is likely to drop (6.3 M) in 2024.

	2021	2022	2023	2024 (projected)
Research Development	8.5M	16.5M	38.8M	40.7M
Other Operating Expenses	14.5M	25.5M	45.0M	47.3M

Research Development Other Operating Expenses

Annovis Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Net Receivables	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Other Assets	Good Will	Net Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Net Invested Capital
Total Assets		0.47	0.62	0.92	0.75	-0.36	0.52	0.93	0.21	-0.03	-0.16	0.65	-0.04	0.99	0.12	-0.15	0.23	0.19	-0.15	-0.92	0.92	0.67	0.62	-0.34	0.7	0.89
Other Current Liab	0.47		0.63	0.16	0.83	-0.89	0.29	0.42	-0.2	-0.27	-0.05	0.89	0.67	0.5	-0.42	-0.23	-0.2	-0.15	-0.3	-0.39	0.38	0.78	0.81	0.44	0.86	0.28
Total Current Liabilities	0.62	0.63		0.42	0.59	-0.47	0.91	0.35	0.54	0.13	0.01	0.52	0.39	0.55	0.36	-0.2	0.57	0.49	-0.26	-0.32	0.32	0.45	0.53	0.14	0.51	0.29
Total Stockholder Equity	0.92	0.16	0.42		0.5	-0.03	0.41	0.89	0.21	0.1	-0.19	0.36	-0.42	0.91	0.24	0.0	0.21	0.15	0.02	-0.9	0.9	0.44	0.39	-0.64	0.43	0.93
Net Tangible Assets	0.75	0.83	0.59	0.5		-0.88	0.34	0.69	-0.05	-0.09	-0.22	0.98	0.45	0.76	-0.24	-0.12	-0.03	0.05	-0.21	-0.66	0.65	0.94	0.86	0.23	0.98	0.54
Retained Earnings	-0.36	-0.89	-0.47	-0.03	-0.88		-0.18	-0.31	0.15	0.17	0.13	-0.93	-0.75	-0.37	0.43	0.2	0.15	0.06	0.32	0.27	-0.26	-0.84	-0.8	-0.61	-0.89	-0.12
Accounts Payable	0.52	0.29	0.91	0.41	0.34	-0.18		0.19	0.82	0.36	0.02	0.22	0.19	0.41	0.69	-0.13	0.85	0.76	-0.16	-0.17	0.16	0.18	0.22	0.03	0.21	0.16
Cash	0.93	0.42	0.35	0.89	0.69	-0.31	0.19		-0.11	-0.24	-0.14	0.63	-0.12	0.97	-0.15	-0.15	-0.1	-0.14	-0.13	-1.0	1.0	0.68	0.63	-0.45	0.7	0.97
Net Receivables	0.21	-0.2	0.54	0.21	-0.05	0.15	0.82	-0.11		0.52	-0.06	-0.18	-0.03	0.09	0.81	-0.2	0.98	0.82	-0.22	0.12	-0.12	-0.2	-0.21	-0.02	-0.19	-0.11
Inventory	-0.03	-0.27	0.13	0.1	-0.09	0.17	0.36	-0.24	0.52		-0.15	-0.24	-0.36	-0.13	0.69	0.57	0.49	0.67	0.53	0.24	-0.25	-0.28	-0.33	0.08	-0.25	-0.24
Other Current Assets	-0.16	-0.05	0.01	-0.19	-0.22	0.13	0.02	-0.14	-0.06	-0.15		-0.17	0.12	-0.16	-0.06	-0.08	-0.06	-0.11	-0.05	0.15	-0.14	-0.19	0.19	0.06	-0.17	-0.13
Other Stockholder Equity	0.65	0.89	0.52	0.36	0.98	-0.93	0.22	0.63	-0.18	-0.24	-0.17		0.56	0.67	-0.39	-0.18	-0.17	-0.09	-0.27	-0.6	0.59	0.95	0.89	0.32	1.0	0.47
Total Liab	-0.04	0.67	0.39	-0.42	0.45	-0.75	0.19	-0.12	-0.03	-0.36	0.12	0.56		-0.04	-0.32	-0.37	0.01	0.02	-0.45	0.17	-0.17	0.39	0.46	0.83	0.5	-0.32
Total Current Assets	0.99	0.5	0.55	0.91	0.76	-0.37	0.41	0.97	0.09	-0.13	-0.16	0.67	-0.04		0.0	-0.17	0.1	0.05	-0.17	-0.96	0.96	0.7	0.66	-0.37	0.73	0.93
Intangible Assets	0.12	-0.42	0.36	0.24	-0.24	0.43	0.69	-0.15	0.81	0.69	-0.06	-0.39	-0.32	0.0		0.35	0.87	0.9	0.36	0.16	-0.15	-0.39	-0.41	-0.19	-0.39	-0.1
Common Stock	-0.15	-0.23	-0.2	0.0	-0.12	0.2	-0.13	-0.15	-0.2	0.57	-0.08	-0.18	-0.37	-0.17	0.35		-0.11	0.27	0.98	0.14	-0.14	-0.2	-0.22	0.0	-0.18	-0.12
Property Plant Equipment	0.23	-0.2	0.57	0.21	-0.03	0.15	0.85	-0.1	0.98	0.49	-0.06	-0.17	0.01	0.1	0.87	-0.11		0.88	-0.13	0.12	-0.12	-0.18	-0.2	-0.01	-0.17	-0.1
Other Assets	0.19	-0.15	0.49	0.15	0.05	0.06	0.76	-0.14	0.82	0.67	-0.11	-0.09	0.02	0.05	0.9	0.27	0.88		0.26	0.16	-0.17	-0.13	-0.21	0.14	-0.1	-0.18
Good Will	-0.15	-0.3	-0.26	0.02	-0.21	0.32	-0.16	-0.13	-0.22	0.53	-0.05	-0.27	-0.45	-0.17	0.36	0.98	-0.13	0.26		0.12	-0.12	-0.27	-0.31	-0.1	-0.26	-0.09
Net Debt	-0.92	-0.39	-0.32	-0.9	-0.66	0.27	-0.17	-1.0	0.12	0.24	0.15	-0.6	0.17	-0.96	0.16	0.14	0.12	0.16	0.12		-1.0	-0.65	-0.61	0.48	-0.67	-0.98
Cash And Short Term Investments	0.92	0.38	0.32	0.9	0.65	-0.26	0.16	1.0	-0.12	-0.25	-0.14	0.59	-0.17	0.96	-0.15	-0.14	-0.12	-0.17	-0.12	-1.0		0.64	0.61	-0.49	0.66	0.98
Common Stock Total Equity	0.67	0.78	0.45	0.44	0.94	-0.84	0.18	0.68	-0.2	-0.28	-0.19	0.95	0.39	0.7	-0.39	-0.2	-0.18	-0.13	-0.27	-0.65	0.64		0.89	0.1	0.96	0.56
Common Stock Shares Outstanding	0.62	0.81	0.53	0.39	0.86	-0.8	0.22	0.63	-0.21	-0.33	0.19	0.89	0.46	0.66	-0.41	-0.22	-0.2	-0.21	-0.31	-0.61	0.61	0.89		0.15	0.9	0.52
Non Current Liabilities Total	-0.34	0.44	0.14	-0.64	0.23	-0.61	0.03	-0.45	-0.02	0.08	0.06	0.32	0.83	-0.37	-0.19	0.0	-0.01	0.14	-0.1	0.48	-0.49	0.1	0.15		0.24	-0.64
Capital Surpluse	0.7	0.86	0.51	0.43	0.98	-0.89	0.21	0.7	-0.19	-0.25	-0.17	1.0	0.5	0.73	-0.39	-0.18	-0.17	-0.1	-0.26	-0.67	0.66	0.96	0.9	0.24		0.54
Net Invested Capital	0.89	0.28	0.29	0.93	0.54	-0.12	0.16	0.97	-0.11	-0.24	-0.13	0.47	-0.32	0.93	-0.1	-0.12	-0.1	-0.18	-0.09	-0.98	0.98	0.56	0.52	-0.64	0.54

Click cells to compare fundamentals

Annovis Bio Account Relationship Matchups

Annovis Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1M	8.1M	46.0M	36.0M	10.2M	14.9M
Other Current Liab	776.9K	236.5K	818.4K	3.7M	3.0M	3.1M
Total Current Liabilities	2.0M	578.4K	1.5M	7.7M	4.3M	3.0M
Total Stockholder Equity	(8.6M)	7.5M	44.5M	28.3M	(7.8M)	(7.4M)
Net Tangible Assets	(7.6M)	(8.6M)	7.5M	44.5M	51.2M	53.7M
Retained Earnings	(8.8M)	(14.2M)	(28.7M)	(54.1M)	(110.3M)	(104.7M)
Accounts Payable	1.2M	341.9K	688.1K	4.0M	1.3M	1.5M
Cash	1.9K	8.1M	45.7M	28.4M	5.8M	9.4M
Other Current Assets	745.7M	38.2K	72.8K	104.9K	41.5K	39.5K
Other Stockholder Equity	200.6K	21.8M	73.2M	82.4M	102.5M	107.6M
Total Liab	9.7M	578.4K	1.5M	7.7M	18.0M	18.9M
Total Current Assets	747.5K	8.1M	46.0M	36.0M	10.2M	12.9M
Net Debt	497.9K	(8.1M)	(45.7M)	(28.4M)	(5.8M)	(6.0M)
Cash And Short Term Investments	1.9K	8.1M	45.7M	28.4M	5.8M	5.5M
Common Stock Shares Outstanding	6.8M	6.3M	7.6M	8.2M	9.0M	7.3M
Liabilities And Stockholders Equity	1.1M	8.1M	46.0M	36.0M	10.2M	16.0M
Non Current Liabilities Total	7.7M	341.9K	688.1K	4.0M	13.7M	14.4M
Capital Surpluse	192.1K	200.6K	21.8M	73.2M	84.2M	88.4M
Net Invested Capital	(8.1M)	7.5M	44.5M	28.3M	(7.8M)	(7.4M)
Net Working Capital	(1.3M)	7.5M	44.5M	28.3M	5.9M	5.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC